| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 9 | 2017 | 310 | 0.810 |
Why?
|
| Radiology | 5 | 2021 | 97 | 0.640 |
Why?
|
| Ultrasonography, Mammary | 5 | 2015 | 39 | 0.530 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2016 | 2223 | 0.500 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2013 | 2324 | 0.460 |
Why?
|
| Ovarian Cysts | 1 | 2013 | 9 | 0.460 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2013 | 21 | 0.460 |
Why?
|
| Breast Neoplasms | 9 | 2017 | 1536 | 0.460 |
Why?
|
| Low Back Pain | 3 | 1997 | 45 | 0.430 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 267 | 0.400 |
Why?
|
| Pelvic Pain | 1 | 2011 | 11 | 0.380 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 163 | 0.340 |
Why?
|
| Ultrasonography | 6 | 2016 | 453 | 0.340 |
Why?
|
| Liver Cirrhosis | 1 | 2012 | 301 | 0.320 |
Why?
|
| Breast Density | 3 | 2017 | 21 | 0.310 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 334 | 0.300 |
Why?
|
| Taste | 2 | 1998 | 49 | 0.280 |
Why?
|
| Mass Screening | 4 | 2017 | 843 | 0.260 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2005 | 25 | 0.260 |
Why?
|
| Phlebography | 1 | 2005 | 31 | 0.260 |
Why?
|
| Sensitivity and Specificity | 7 | 2016 | 1753 | 0.250 |
Why?
|
| Female | 32 | 2020 | 38074 | 0.250 |
Why?
|
| Breast Diseases | 2 | 2016 | 40 | 0.250 |
Why?
|
| Leg | 1 | 2005 | 191 | 0.240 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 125 | 0.230 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2015 | 62 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 772 | 0.230 |
Why?
|
| Internship and Residency | 2 | 2021 | 596 | 0.220 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 253 | 0.210 |
Why?
|
| Middle Aged | 25 | 2017 | 21147 | 0.210 |
Why?
|
| Humans | 41 | 2021 | 68618 | 0.210 |
Why?
|
| ROC Curve | 4 | 2013 | 392 | 0.200 |
Why?
|
| Family Leave | 1 | 2021 | 2 | 0.190 |
Why?
|
| Sick Leave | 1 | 2021 | 6 | 0.190 |
Why?
|
| Policy | 1 | 2021 | 58 | 0.190 |
Why?
|
| Adult | 23 | 2017 | 21403 | 0.180 |
Why?
|
| Ultrasonography, Doppler | 3 | 2009 | 57 | 0.170 |
Why?
|
| Ribonucleases | 3 | 2000 | 25 | 0.170 |
Why?
|
| Aged | 16 | 2017 | 14862 | 0.160 |
Why?
|
| Carbonated Beverages | 1 | 1998 | 9 | 0.160 |
Why?
|
| Sweetening Agents | 1 | 1998 | 23 | 0.160 |
Why?
|
| Mobile Health Units | 1 | 2017 | 18 | 0.150 |
Why?
|
| Personal Satisfaction | 1 | 1998 | 123 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.150 |
Why?
|
| Intervertebral Disc Displacement | 1 | 1997 | 17 | 0.150 |
Why?
|
| Temporomandibular Joint | 1 | 2016 | 18 | 0.140 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2016 | 20 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 352 | 0.140 |
Why?
|
| Aged, 80 and over | 9 | 2016 | 4848 | 0.140 |
Why?
|
| Residence Characteristics | 1 | 1998 | 252 | 0.140 |
Why?
|
| Radiologists | 1 | 2016 | 35 | 0.140 |
Why?
|
| Receptors, Progesterone | 2 | 2013 | 57 | 0.130 |
Why?
|
| Wine | 1 | 1995 | 4 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 177 | 0.130 |
Why?
|
| Diagnostic Imaging | 3 | 2007 | 201 | 0.130 |
Why?
|
| Graft Rejection | 2 | 2009 | 458 | 0.130 |
Why?
|
| Receptors, Estrogen | 2 | 2013 | 142 | 0.130 |
Why?
|
| Receptor, ErbB-2 | 2 | 2013 | 129 | 0.120 |
Why?
|
| Fractures, Bone | 2 | 1993 | 132 | 0.120 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 237 | 0.120 |
Why?
|
| Male | 16 | 2016 | 37321 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1995 | 346 | 0.120 |
Why?
|
| Ovary | 1 | 2013 | 99 | 0.110 |
Why?
|
| Brachytherapy | 2 | 2011 | 79 | 0.110 |
Why?
|
| Radiology Information Systems | 1 | 1993 | 21 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 504 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 1140 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2016 | 413 | 0.100 |
Why?
|
| Blood Proteins | 3 | 2000 | 94 | 0.100 |
Why?
|
| Radiographic Image Enhancement | 2 | 1993 | 208 | 0.100 |
Why?
|
| Sentinel Surveillance | 1 | 2012 | 20 | 0.100 |
Why?
|
| Occupational Health Nursing | 2 | 2009 | 2 | 0.100 |
Why?
|
| Biliary Dyskinesia | 1 | 2011 | 7 | 0.100 |
Why?
|
| Pneumonia | 1 | 1993 | 110 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2016 | 657 | 0.100 |
Why?
|
| Mesenteric Lymphadenitis | 1 | 2011 | 2 | 0.100 |
Why?
|
| Ureteral Calculi | 1 | 2011 | 4 | 0.100 |
Why?
|
| Diverticulitis | 1 | 2011 | 6 | 0.100 |
Why?
|
| Uterine Perforation | 1 | 2011 | 3 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 369 | 0.100 |
Why?
|
| Intestinal Obstruction | 1 | 2011 | 36 | 0.090 |
Why?
|
| Kidney Transplantation | 2 | 2009 | 839 | 0.090 |
Why?
|
| Uterus | 1 | 2011 | 77 | 0.090 |
Why?
|
| Eosinophils | 2 | 2000 | 60 | 0.090 |
Why?
|
| Appendicitis | 1 | 2011 | 55 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2011 | 119 | 0.090 |
Why?
|
| Ascitic Fluid | 1 | 2009 | 22 | 0.090 |
Why?
|
| Paracentesis | 1 | 2009 | 25 | 0.090 |
Why?
|
| Ascites | 1 | 2009 | 38 | 0.090 |
Why?
|
| Colitis | 1 | 2011 | 156 | 0.090 |
Why?
|
| Retrospective Studies | 7 | 2017 | 7277 | 0.080 |
Why?
|
| Onchocerciasis | 1 | 1989 | 4 | 0.080 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2009 | 14 | 0.080 |
Why?
|
| Kidney Diseases | 2 | 2009 | 307 | 0.080 |
Why?
|
| World Health Organization | 1 | 2008 | 53 | 0.080 |
Why?
|
| Disease Progression | 1 | 2012 | 1038 | 0.080 |
Why?
|
| International Classification of Diseases | 1 | 2008 | 85 | 0.080 |
Why?
|
| Granular Cell Tumor | 1 | 2008 | 9 | 0.080 |
Why?
|
| Pregnancy | 2 | 2011 | 2334 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 286 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2011 | 300 | 0.080 |
Why?
|
| Myelography | 2 | 1997 | 10 | 0.070 |
Why?
|
| Evidence-Based Practice | 1 | 2009 | 146 | 0.070 |
Why?
|
| Radiography | 2 | 2020 | 572 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 2007 | 14 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2012 | 1330 | 0.070 |
Why?
|
| Emergency Medical Technicians | 1 | 2007 | 14 | 0.070 |
Why?
|
| Fires | 1 | 2007 | 21 | 0.070 |
Why?
|
| Volunteers | 1 | 2007 | 30 | 0.070 |
Why?
|
| Opportunistic Infections | 1 | 2007 | 33 | 0.070 |
Why?
|
| United States | 4 | 2021 | 7367 | 0.070 |
Why?
|
| Contrast Media | 2 | 2011 | 595 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 1465 | 0.070 |
Why?
|
| Dairying | 1 | 2006 | 6 | 0.070 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 22 | 0.070 |
Why?
|
| Rural Health Services | 1 | 2007 | 101 | 0.070 |
Why?
|
| Organ Transplantation | 1 | 2007 | 110 | 0.060 |
Why?
|
| Regression Analysis | 2 | 1997 | 737 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2007 | 358 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 446 | 0.060 |
Why?
|
| Language | 1 | 2006 | 120 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 375 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 2077 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 1997 | 1046 | 0.060 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2004 | 23 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2016 | 3705 | 0.060 |
Why?
|
| Research Design | 2 | 2017 | 729 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2005 | 344 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 323 | 0.050 |
Why?
|
| Colonoscopy | 1 | 2004 | 156 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2009 | 1615 | 0.050 |
Why?
|
| Stents | 1 | 2006 | 657 | 0.050 |
Why?
|
| Radiation Oncology | 1 | 2021 | 12 | 0.050 |
Why?
|
| Radiology, Interventional | 1 | 2021 | 21 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2000 | 71 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2016 | 502 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2020 | 85 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 2000 | 44 | 0.040 |
Why?
|
| Eosinophil Granule Proteins | 3 | 2000 | 5 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2000 | 626 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 116 | 0.040 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 508 | 0.040 |
Why?
|
| Aspartame | 1 | 1998 | 1 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2004 | 561 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 1998 | 39 | 0.040 |
Why?
|
| Sucrose | 1 | 1998 | 58 | 0.040 |
Why?
|
| Arachidonic Acids | 1 | 1998 | 97 | 0.040 |
Why?
|
| Biopsy | 2 | 2016 | 540 | 0.040 |
Why?
|
| Serotonin | 1 | 1998 | 144 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2000 | 275 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2009 | 134 | 0.040 |
Why?
|
| Mast Cells | 1 | 1998 | 113 | 0.040 |
Why?
|
| Intervertebral Disc Chemolysis | 1 | 1997 | 1 | 0.040 |
Why?
|
| Nurse's Role | 2 | 2009 | 66 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 1997 | 18 | 0.040 |
Why?
|
| Absenteeism | 1 | 1997 | 27 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 1997 | 108 | 0.040 |
Why?
|
| Spine | 1 | 1997 | 46 | 0.040 |
Why?
|
| Analgesia, Epidural | 1 | 1997 | 40 | 0.040 |
Why?
|
| Social Class | 1 | 1997 | 127 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1997 | 51 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 3259 | 0.030 |
Why?
|
| Feedback | 1 | 2016 | 90 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 83 | 0.030 |
Why?
|
| Accreditation | 1 | 2016 | 72 | 0.030 |
Why?
|
| Premenopause | 1 | 2016 | 57 | 0.030 |
Why?
|
| New York | 2 | 2007 | 223 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 1997 | 133 | 0.030 |
Why?
|
| Postmenopause | 1 | 2016 | 93 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 330 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2016 | 110 | 0.030 |
Why?
|
| Linear Models | 1 | 1997 | 521 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2000 | 902 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1995 | 193 | 0.030 |
Why?
|
| Calcinosis | 1 | 2016 | 241 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 652 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 214 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 442 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2016 | 287 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 1997 | 1054 | 0.030 |
Why?
|
| X-Ray Film | 1 | 1993 | 16 | 0.030 |
Why?
|
| Logistic Models | 1 | 1997 | 1420 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2016 | 310 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 5731 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 111 | 0.030 |
Why?
|
| Lasers | 1 | 1993 | 61 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2011 | 2007 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 1342 | 0.030 |
Why?
|
| Curriculum | 1 | 2016 | 575 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 454 | 0.030 |
Why?
|
| Child | 2 | 2013 | 6405 | 0.030 |
Why?
|
| Gallbladder Emptying | 1 | 2011 | 4 | 0.030 |
Why?
|
| Imino Acids | 1 | 2011 | 7 | 0.030 |
Why?
|
| Cholecystokinin | 1 | 2011 | 29 | 0.020 |
Why?
|
| Technetium | 1 | 2011 | 38 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2007 | 7029 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2011 | 125 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 160 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 800 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 333 | 0.020 |
Why?
|
| Health Fairs | 1 | 2009 | 1 | 0.020 |
Why?
|
| Eosinophil Peroxidase | 1 | 1989 | 1 | 0.020 |
Why?
|
| Onchocerca | 1 | 1989 | 4 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.020 |
Why?
|
| New England | 1 | 2009 | 16 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1989 | 19 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2009 | 46 | 0.020 |
Why?
|
| Models, Nursing | 1 | 2009 | 23 | 0.020 |
Why?
|
| Peroxidases | 1 | 1989 | 28 | 0.020 |
Why?
|
| Neurotoxins | 1 | 1989 | 30 | 0.020 |
Why?
|
| Exocytosis | 1 | 1989 | 34 | 0.020 |
Why?
|
| Adolescent | 2 | 2013 | 8912 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2008 | 41 | 0.020 |
Why?
|
| Urethral Obstruction | 1 | 2008 | 8 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 219 | 0.020 |
Why?
|
| Mastectomy, Segmental | 1 | 2007 | 64 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 191 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2007 | 55 | 0.020 |
Why?
|
| Peptides | 2 | 2000 | 455 | 0.020 |
Why?
|
| Workplace | 1 | 2007 | 75 | 0.020 |
Why?
|
| Self Care | 1 | 2009 | 253 | 0.020 |
Why?
|
| Vermont | 1 | 2006 | 21 | 0.020 |
Why?
|
| Age Distribution | 1 | 2007 | 320 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2007 | 115 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2006 | 46 | 0.020 |
Why?
|
| Cause of Death | 1 | 2007 | 241 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 425 | 0.020 |
Why?
|
| Career Mobility | 1 | 2006 | 34 | 0.020 |
Why?
|
| Health Services Research | 1 | 2007 | 209 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2007 | 285 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2007 | 166 | 0.020 |
Why?
|
| Telemedicine | 1 | 1993 | 700 | 0.020 |
Why?
|
| Workload | 1 | 2006 | 103 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 500 | 0.020 |
Why?
|
| Kidney | 1 | 2009 | 945 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 514 | 0.010 |
Why?
|
| Inflammation | 1 | 1989 | 1030 | 0.010 |
Why?
|
| Eosinophil-Derived Neurotoxin | 1 | 2000 | 2 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2000 | 117 | 0.010 |
Why?
|
| Intestines | 1 | 2000 | 114 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1998 | 22 | 0.010 |
Why?
|
| Ionophores | 1 | 1998 | 25 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 742 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 78 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1998 | 52 | 0.010 |
Why?
|
| Histamine | 1 | 1998 | 52 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1998 | 91 | 0.010 |
Why?
|
| Gene Expression | 1 | 2000 | 770 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5717 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1998 | 217 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 492 | 0.010 |
Why?
|
| Animals | 2 | 1998 | 20881 | 0.010 |
Why?
|
| Proteins | 1 | 2000 | 474 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 397 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2000 | 2673 | 0.010 |
Why?
|
| Calcium | 1 | 1998 | 929 | 0.010 |
Why?
|
| Cell Line | 1 | 1998 | 1752 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1998 | 1034 | 0.010 |
Why?
|
| Computer Terminals | 1 | 1993 | 4 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1993 | 100 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 5300 | 0.010 |
Why?
|
| Mice | 1 | 1998 | 8474 | 0.000 |
Why?
|
| Surveys and Questionnaires | 1 | 1993 | 2800 | 0.000 |
Why?
|